Ocera Therap (OCRX) Misses Q1 EPS by 1c

Ocera Therap (NASDAQ: OCRX) reported Q1 EPS of ($0.46), $0.01 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $33 thousand versus the consensus estimate of $200 thousand.

For earnings history and earnings-related data on Ocera Therap (OCRX) click here.

You May Also Be Interested In

• BW LPG Limited (BWLP) Reports Q1 EPS of $0.79
• Marvell (MRVL) Stock: Risk/Reward Skewed to the Upside Near-Term Following Selloff, Says Analyst
• Hub Group faces credibility test as Q2 report looms Sept. 1